Therapeutic Promise of Mitophagy in Cancer: Advancing from Small-Molecule Regulation to Nanotechnology-Enhanced Targeting Therapy
Theranostics · 30.01.2026 · 16 (8) · 4308-4335
DOI: 10.7150/thno.129867 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 30.01.2026. Verfasst von Ping Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related…. Hauptthemen laut MEDLINE: Mitophagy, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Mitophagy, a selective autophagic pathway that clears damaged or dysfunctional mitochondria, has emerged as a promising therapeutic approach. Mitophagy maintains a delicate balance between cell survival and death, while mounting evidence suggests that it predominantly promotes tumor cell survival under stress, particularly in responses to cancer therapy. Moreover, aberrant regulation of mitophagy results in cancer pathology with characteristic hallmarks, including remodeling of metabolic plasticity, maintenance of cancer stem cell characteristics, and immune regulation of the tumor microenvironment. This review synthesizes multifaceted roles of mitophagy in cancer biology, from tumor initiation and progression to therapy responses. It also summarizes molecular mechanisms underlying mitophagy. How cancer cells exploit mitophagy to survive therapy has been harnessed to develop therapeutic strategies. We elaborate the evolution of mitophagic therapy from small-molecule modulators to nanotechnology-based targeted delivery systems. Finally, we highlight the promise of targeting mitophagy in overcoming treatment resistance and improving clinical outcomes for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, National Clinical Research Center for Geriatrics,…
- XiangYa School of Medicine, Central South University, 172 Tongzipo Road, YueLu District, 410013 Changsha, Hunan, China.
- Psychoradiology Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu 610041, China.
- Xiamen Key Lab of Psychoradiology and Neuromodulation, Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen 361021, China.
Zitieren
APA
Chen, P., Liu, G., Yin, J., Sun, L., Wang, X., Wang, B., Gong, Q., & Luo, K. (2026). Therapeutic Promise of Mitophagy in Cancer: Advancing from Small-Molecule Regulation to Nanotechnology-Enhanced Targeting Therapy. Theranostics, 16(8), 4308-4335. https://doi.org/10.7150/thno.129867
Vancouver
Chen P, Liu G, Yin J, Sun L, Wang X, Wang B, et al. Therapeutic Promise of Mitophagy in Cancer: Advancing from Small-Molecule Regulation to Nanotechnology-Enhanced Targeting Therapy. Theranostics. 2026;16(8):4308-4335. doi:10.7150/thno.129867
BibTeX
@article{Chen2026,
author = {Chen, Ping and Liu, Guohao and Yin, Jiani and Sun, Ling and Wang, Xiaoming and Wang, Bing and Gong, Qiyong and Luo, Kui},
title = {Therapeutic Promise of Mitophagy in Cancer: Advancing from Small-Molecule Regulation to Nanotechnology-Enhanced Targeting Therapy},
journal = {Theranostics},
year = {2026},
volume = {16},
number = {8},
pages = {4308--4335},
doi = {10.7150/thno.129867}
}
EUVIMED